VivoSim Labs VIVS
NASDAQ VIVS
$0.16 +0.00 (+1.34%)
As of: Oct 19, 2026 · 3:56 PM EDT

VivoSim Labs (VIVS) Notes Payables (2011)

Updated

VivoSim Labs' Notes Payables came in at $704,000 for fiscal Q4 2011 (quarter ended Dec 31, 2011).

Analysis

VivoSim Labs (VIVS) Notes Payables (2011) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.17 Bn 35.87 Bn 1.44 Bn
2 Medpace Holdings 17.45 Bn 15.51 Bn 201.64 Mn
3 Charles River Laboratories International 14.37 Bn 13.56 Bn 363.37 Mn
4 Icon 13.16 Bn 10.27 Bn 479.29 Mn
5 Fortrea Holdings 2.12 Bn 1.50 Bn 139.20 Mn
6 Ginkgo Bioworks Holdings 625.60 Mn -136.48 Mn 18.44 Mn
7 Evotec SE 506.10 Mn -1.10 Bn -
8 Champions Oncology 65.60 Mn 40.68 Mn 7.70 Mn
9 MindWalk Holdings 61.22 Mn 24.88 Mn 1.61 Mn
10 VivoSim Labs 832,550.47 -16.89 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 704,000.00
API Access

VivoSim Labs Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=VIVS&period=max&api_key=YOUR_API_KEY